Association between Sleep Disturbances and Medial Temporal Lobe Volume in Older Adults with Mild Cognitive Impairment Free of Lifetime History of Depression
Restricted accessResearch articleFirst published online May 21, 2019
Association between Sleep Disturbances and Medial Temporal Lobe Volume in Older Adults with Mild Cognitive Impairment Free of Lifetime History of Depression
Previous studies examining the link between neuropsychiatric symptoms (NPS) and biomarkers of Alzheimer’s disease (AD) may be confounded by remitted or past history of psychiatric illness, which in itself is associated with AD biomarkers such as reduced medial temporal lobe (MTL) volume.
Objective:
We examined associations between mood and anxiety-related NPS and MTL in older adults with mild cognitive impairment (MCI) free of lifetime history of depression. We hypothesized an inverse relationship between NPS severity and MTL.
Methods:
Forty-two MCI participants without current or past history of depression or other major psychiatric illness were assessed using the Neuropsychiatric Inventory-Questionnaire (NPI-Q). Correlation and regression analyses were performed between selected NPI-Q items and regional MTL volumes from structural magnetic resonance imaging.
Results:
Sleep disturbances were inversely associated with several regional volumes within the MTL. Sleep disturbances remained significantly correlated with left hippocampal and amygdala volume following correction for multiple comparisons. In contrast, depression and anxiety were not correlated with MTL.
Conclusions:
The relationship between reduced MTL and sleep, but not with depressed or anxious states, in MCI free of lifetime history of depression, suggests a potential mechanism for sleep as a risk factor for AD. The current findings highlight the importance of accounting for remitted psychiatric conditions in studies of the link between NPS and AD biomarkers and support the need for further research on sleep as clinical biomarker of AD and target for AD prevention.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
2.
MisraC, FanY, DavatzikosC (2009) Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI. Neuroimage44, 1415–1422.
3.
VisserP, VerheyF, HofmanP, ScheltensP, JollesJ (2002) Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry72, 491–497.
4.
SommeJ, Fernandez-MartinezM, MolanoA, ZarranzJJ (2013) Neuropsychiatric symptoms in amnestic mild cognitive impairment: Increased risk and faster progression to dementia. Curr Alzheimer Res10, 86–94.
5.
DillonC, SerranoCM, CastroD, LeguizamonPP, HeiseckeSL, TaraganoFE (2013) Behavioral symptoms related to cognitive impairment. Neuropsychiatr Dis Treat9, 1443–1455.
6.
OwnbyRL, CroccoE, AcevedoA, JohnV, LoewensteinD (2006) Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry63, 530–538.
7.
MahL, BinnsMA, SteffensDC (2015) Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease. Am J Geriatr Psychiatry23, 466–476.
8.
MonasteroR, MangialascheF, CamardaC, ErcolaniS, CamardaR (2009) A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis18, 11–30.
9.
KohlerCA, MagalhaesTF, OliveiraJM, AlvesGS, KnochelC, Oertel-KnochelV, PantelJ, CarvalhoAF (2016) Neuropsychiatric disturbances in mild cognitive impairment (MCI): A systematic review of population-based studies. Curr Alzheimer Res13, 1066–1082.
10.
CummingsJL (1997) The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology48, S10–16.
11.
KauferDI, CummingsJL, KetchelP, SmithV, MacMillanA, ShelleyT, LopezOL, DeKoskyST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci12, 233–239.
12.
CummingsJL, MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology44, 2308–2314.
13.
TaraganoFE, AllegriRF (2003) Mild behavioural impairment: The early diagnosis. Int Psychogeriatr15, 1.
14.
IsmailZ, SmithEE, GedaY, SultzerD, BrodatyH, SmithG, Aguera-OrtizL, SweetR, MillerD, LyketsosCG (2016) Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement12, 195–202.
15.
WhitwellJL, PetersenRC, NegashS, WeigandSD, KantarciK, IvnikRJ, KnopmanDS, BoeveBF, SmithGE, JackCRJr (2007) Patterns of atrophy differ among specific subtypes of mild cognitive impairment. Arch Neurol64, 1130–1138.
PinkA, PrzybelskiSA, Krell-RoeschJ, StokinGB, RobertsRO, MielkeMM, SpangehlKA, KnopmanDS, JackCRJr, PetersenRC, GedaYE (2017) Cortical thickness and anxiety symptoms among cognitively normal elderly persons: The Mayo Clinic Study of Aging. J Neuropsychiatry Clin Neurosci29, 60–66.
20.
McKinnonMC, YucelK, NazarovA, MacQueenGM (2009) A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci34, 41–54.
21.
SmithME (2005) Bilateral hippocampal volume reduction in adults with post-traumatic stress disorder: A meta-analysis of structural MRI studies. Hippocampus15, 798–807.
22.
ChungJK, PlitmanE, NakajimaS, ChowTW, ChakravartyMM, CaravaggioF, GerretsenP, BrownEE, IwataY, MulsantBH, Graff-GuerreroA (2015) Lifetime history of depression predicts increased amyloid-beta accumulation in patients with mild cognitive impairment. J Alzheimers Dis45, 907–919.
23.
FirstMB, SpitzerRL, GibbonM, WilliamsJBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P).Biometrics Research, State Psychiatric Institute. New York.
24.
APA (2013) Diagnostic and statistical manual of mental disorders. 5th ed., American Psychiatric Press, Arlington, VA.
25.
FischlB, SalatDH, BusaE, AlbertM, DieterichM, HaselgroveC, van der KouweA, KillianyR, KennedyD, KlavenessS, MontilloA, MakrisN, RosenB, DaleAM (2002) Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron33, 341–355.
26.
DesikanRS, SegonneF, FischlB, QuinnBT, DickersonBC, BlackerD, BucknerRL, DaleAM, MaguireRP, HymanBT, AlbertMS, KillianyRJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage31, 968–980.
27.
SterniczukR, TheouO, RusakB, RockwoodK (2013) Sleep disturbance is associated with incident dementia and mortality. Curr Alzheimer Res10, 767–775.
28.
Beaulieu-BonneauS, HudonC (2009) Sleep disturbances in older adults with mild cognitive impairment. Int Psychogeriatr21, 654–666.
29.
OsorioRS, PirragliaE, Agüera-OrtizLF, DuringEH, SacksH, AyappaI, WalslebenJ, MooneyA, HussainA, GlodzikL, FrangioneB, Martínez-MartínP, de LeonMJ (2011) Greater risk of Alzheimer’s disease in older adults with insomnia. J Am Geriatr Soc59, 559–562.
30.
YaffeK, LaffanAM, HarrisonSL, RedlineS, SpiraAP, EnsrudKE, Ancoli-IsraelS, StoneKL (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA306, 613–619.
31.
ManderBA, WinerJR, JagustWJ, WalkerMP (2016) Sleep: A novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer’s disease?Trends Neurosci39, 552–566.
32.
BrangerP, Arenaza-UrquijoEM, TomadessoC, MezengeF, AndreC, de FloresR, MutluJ, de La SayetteV, EustacheF, ChetelatG, RauchsG (2016) Relationships between sleep quality and brain volume, metabolism, and amyloid deposition in late adulthood. Neurobiol Aging41, 107–114.
33.
MuellerSG, WeinerMW, ThalLJ, PetersenRC, JackCR, JagustW, TrojanowskiJQ, TogaAW, BeckettL (2005) Ways toward an early diagnosis in Alzheimer’s disease: The Alzheimer’s Disease Neuroimaging Initiative (ADNI). Alzheimers Dement1, 55–66.
34.
AnsteyKJ, CherbuinN, BudgeM, YoungJ (2011) Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obes Rev12, e426–437.
35.
JakAJ, UrbanS, McCauleyA, BangenKJ, Delano-WoodL, Corey-BloomJ, BondiMW (2009) Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsychol Soc15, 890–897.
Bell-McGintyS, LopezOL, MeltzerCC, ScanlonJM, WhyteEM, DekoskyST, BeckerJT (2005) Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol62, 1393–1397.
38.
WhitwellJL, ShiungMM, PrzybelskiSA, WeigandSD, KnopmanDS, BoeveBF, PetersenRC, JackCRJr (2008) MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology70, 512–520.
